Compare Stocks

→ The Gold Grab of the Century (From Colonial Metals) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BMN Blackrock 2037 Municipal Target Term Trust	$24.05 +0.5%	$23.98	$21.51 ▼ $25.59	N/A	N/A	21,827 shs	5,160 shs
EMH Emerald Health Therapeutics	C$0.26 -3.8%	C$0.26	C$0.15 ▼ C$0.53	C$52.28M	N/A	644,760 shs	384,329 shs
KOD Kodiak Sciences	$3.77 +1.9%	$4.91	$1.37 ▼ $9.80	$198M	2.25	463,507 shs	305,707 shs

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BMN Blackrock 2037 Municipal Target Term Trust	+0.46%	+0.33%	+0.25%	-0.74%	+2,404,999,900.00%
EMH Emerald Health Therapeutics	0.00%	0.00%	0.00%	0.00%	0.00%
KOD Kodiak Sciences	+1.89%	+14.94%	-11.71%	-6.45%	-14.51%

$21,000 in profits in six weeks? (Ad)

On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.

Click here for details.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BMN Blackrock 2037 Municipal Target Term Trust	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EMH Emerald Health Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
KOD Kodiak Sciences	3.067 of 5 stars	2.9	0.0	0.0	4.6	1.9	3.3	1.3

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BMN Blackrock 2037 Municipal Target Term Trust	N/A	N/A	N/A	N/A
EMH Emerald Health Therapeutics	N/A	N/A	N/A	N/A
KOD Kodiak Sciences	1.71	Reduce	$5.50	45.89% Upside

Current Analyst Ratings

Latest BMN, RBW, EMH, and KOD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
4/4/2024	KOD Kodiak Sciences	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$3.00 ➝ $5.00
4/1/2024	KOD Kodiak Sciences	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underweight ➝ Underweight	$2.00 ➝ $3.00

(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BMN Blackrock 2037 Municipal Target Term Trust	$11.91M	N/A	N/A	N/A	N/A	N/A
EMH Emerald Health Therapeutics	C$13.02M	4.02	C$0.33 per share	0.78	C$0.40 per share	0.64
KOD Kodiak Sciences	N/A	N/A	N/A	N/A	$5.07 per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BMN Blackrock 2037 Municipal Target Term Trust	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
EMH Emerald Health Therapeutics	N/A	-C$0.70	N/A	∞	N/A	N/A	N/A	N/A	N/A
KOD Kodiak Sciences	-$260.49M	-$4.96	N/A	N/A	N/A	N/A	-80.20%	-46.17%	5/20/2024 (Estimated)

Latest BMN, RBW, EMH, and KOD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/28/2024	Q4 2023	KOD Kodiak Sciences	-$0.86	-$1.13	-$0.27	-$1.13	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BMN Blackrock 2037 Municipal Target Term Trust	$1.12	4.66%	N/A	N/A	1 Years
EMH Emerald Health Therapeutics	N/A	N/A	N/A	N/A	N/A
KOD Kodiak Sciences	N/A	N/A	N/A	N/A	N/A

Latest BMN, RBW, EMH, and KOD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/1/2024	BMN Blackrock 2037 Municipal Target Term Trust	Monthly	$0.0940	4.71%	5/14/2024	5/15/2024	6/3/2024
4/1/2024	BMN Blackrock 2037 Municipal Target Term Trust	Monthly	$0.0940	4.68%	4/12/2024	4/15/2024	5/1/2024
3/1/2024	BMN Blackrock 2037 Municipal Target Term Trust	Monthly	$0.0940	4.72%	3/14/2024	3/15/2024	4/1/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BMN Blackrock 2037 Municipal Target Term Trust	N/A	N/A	N/A
EMH Emerald Health Therapeutics	35.45	2.97	2.61
KOD Kodiak Sciences	N/A	6.93	6.93

Ownership

Institutional Ownership

Company	Institutional Ownership
BMN Blackrock 2037 Municipal Target Term Trust	N/A
EMH Emerald Health Therapeutics	N/A
KOD Kodiak Sciences	89.06%

Insider Ownership

Company	Insider Ownership
BMN Blackrock 2037 Municipal Target Term Trust	N/A
EMH Emerald Health Therapeutics	N/A
KOD Kodiak Sciences	45.40%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
BMN Blackrock 2037 Municipal Target Term Trust	N/A	N/A	N/A	N/A
EMH Emerald Health Therapeutics	161	205.03 million	N/A	Not Optionable
KOD Kodiak Sciences	116	52.52 million	28.68 million	Optionable

BMN, RBW, EMH, and KOD Headlines

Source	Headline
	Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform prnewswire.com - May 2 at 4:30 PM
	Which Species Of Bear Is The Largest On Earth? iflscience.com - May 1 at 10:54 AM
	Florida officials monitor over 30% increase in wildlife calls msn.com - April 30 at 4:07 AM
	Future European tank to be built by 4-party French and German industry venture breakingdefense.com - April 29 at 6:06 PM
	Tractor-trailers with no one aboard? The future is near for self-driving trucks on US roads. msn.com - April 29 at 8:39 AM
	Kodiak Sciences Inc (KOD) investing.com - April 27 at 2:45 AM
	This Is the Meal Where You’re Most Likely Falling Short on Your Protein Goals, Says an RD wellandgood.com - April 26 at 10:00 PM
	Innovators Win with Solutions to Tool Storage, Earbuds, and Tire Traction akbizmag.com - April 26 at 4:59 PM
	Report portrays mixed picture of Alaska’s huge seafood industry msn.com - April 26 at 4:59 PM
	How the Great Alaska Earthquake Shook Up Science msn.com - April 26 at 4:59 PM
	Kodiak Sciences Inc. (NASDAQ:KOD) Receives Average Recommendation of "Reduce" from Analysts americanbankingnews.com - April 26 at 3:06 AM
	How climate change impacts Virginia richmond.com - April 23 at 2:36 PM
	From tiny critters to big bears, here’s how to see Alaska’s wildlife safely adn.com - April 23 at 2:36 PM
	Popular superhero movies fuel lucrative hobby for Kodiak comic collectors alaskapublic.org - April 20 at 12:44 PM
	Amazon has a bulk snack sale going on just in time for 4/20 popsci.com - April 20 at 12:44 PM
	Kodiak Sciences (KOD) Price Target Increased by 11.84% to 4.34 msn.com - April 17 at 11:13 PM
	HOUSING IN KODIAK: Is Airbnb taking over Kodiak’s housing market? kodiakdailymirror.com - April 12 at 10:37 PM
	Will Kodiak Sciences (NASDAQ:KOD) Spend Its Cash Wisely? finance.yahoo.com - April 11 at 1:47 PM
	Kodiak (KOD) Counts on Tarcocimab Program Despite Setbacks zacks.com - April 4 at 1:11 PM
	UBS Group Boosts Kodiak Sciences (NASDAQ:KOD) Price Target to $5.00 marketbeat.com - April 4 at 12:45 PM
	Research Analysts Offer Predictions for Kodiak Sciences Inc.'s FY2024 Earnings (NASDAQ:KOD) marketbeat.com - April 4 at 9:14 AM
	Alaska schools could buckle down on civics yahoo.com - April 3 at 11:14 AM
	Kodiak (KOD) Stock Falls on Q4 Earnings Miss, Pipeline in Focus zacks.com - April 1 at 1:00 PM
	Kodiak Sciences Inc. (KOD) Q4 2023 Earnings Call Transcript seekingalpha.com - March 30 at 7:17 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Blackrock 2037 Municipal Target Term Trust

NYSE:BMN

Blackrock 2037 Municipal Target Term Trust is an close-ended fixed income mutual fund launched by Blackrock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in fixed income markets. The fund primarily invests in n investment grade municipal securities that are rated BBB- or above by S&P and Fitch or Baa3 or above by Moody's. Blackrock 2037 Municipal Target Term Trust is domiciled in the United States.

Emerald Health Therapeutics

CVE:EMH

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Kodiak Sciences

NASDAQ:KOD

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial